Stock Indexes - Apr 25, 2025
Search for a stock to start your analysis
Accurate information on 100,000+ stocks and funds, including all the companies in the S&P500 index. See stock prices, news, financials, forecasts, charts and more.
Top Gainers
Updated Apr 25, 2025Symbol | Name | Price | Change |
---|---|---|---|
PHOE | Phoenix Asia Holdings | $6,995.00 | 174,775.00% |
WW | WW International | $0.40 | 168.02% |
OMEX | Odyssey Marine Exploration | $1.51 | 77.21% |
RTC | Baijiayun Group | $0.33 | 75.42% |
ULY | Urgent.ly | $7.64 | 63.60% |
GREE | Greenidge Generation Holdings | $1.34 | 56.29% |
SXTC | China SXT Pharmaceuticals | $2.29 | 44.94% |
JAGX | Jaguar Health | $10.91 | 35.36% |
NCL | Northann | $0.39 | 32.43% |
MIGI | Mawson Infrastructure Group | $0.60 | 30.58% |
Top Losers
Updated Apr 25, 2025Symbol | Name | Price | Change |
---|---|---|---|
CGTL | Creative Global Technology Holdings | $1.51 | -75.25% |
COEP | Coeptis Therapeutics Holdings | $7.70 | -38.25% |
INTS | Intensity Therapeutics | $0.57 | -37.14% |
SMMT | Summit Therapeutics | $23.47 | -36.06% |
TIL | Instil Bio | $12.78 | -34.83% |
SAIA | Saia, Inc. | $245.63 | -30.66% |
STRO | Sutro Biopharma | $0.90 | -30.57% |
AZUL | Azul S.A. | $0.83 | -26.54% |
VYNE | VYNE Therapeutics | $1.44 | -23.40% |
LEXX | Lexaria Bioscience | $1.35 | -20.12% |
Market News
Recent IPOs
Date | Symbol | Name |
---|---|---|
Apr 25 | CHAC | Crane Harbor Acquisition |
Apr 25 | PHOE | Phoenix Asia Holdings |
Apr 24 | NPAC | New Providence Acquisition Corp. III |
Apr 23 | TVA | Texas Ventures Acquisition III |
Apr 22 | CIGL | Concorde International Group |
Apr 22 | PFAI | Pinnacle Food Group |
Apr 21 | TMDE | TMD Energy |
Apr 17 | EDHL | Everbright Digital Holding |
Upcoming IPOs
Date | Symbol | Name |
---|---|---|
Apr 25 | IPCX | Inflection Point Acquisition Corp. III |
Apr 29 | RAAQ | Real Asset Acquisition |
Apr 29 | DAAQ | Digital Asset Acquisition |
Apr 29 | OMSE | OMS Energy Technologies |
Apr 30 | YB | Yuanbao |
May 1 | EGG | Enigmatig |
May 2 | FMFC | Kandal M Venture |